Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mechanisms of Anthracycline-Induced Cardiotoxicity: Is Mitochondrial Dysfunction the Answer?
Alessandra Murabito, Emilio Hirsch, Alessandra Ghigo
Frontiers in Cardiovascular Medicine (2020) Vol. 7
Open Access | Times Cited: 81

Showing 26-50 of 81 citing articles:

Anthracycline in Medicinal Chemistry: Mechanism of Cardiotoxicity, Preventive and Treatment Strategies
Narmin Hamaamin Hussen, Aso Hameed Hasan, Gashbeen Osman Muhammed, et al.
Current Organic Chemistry (2023) Vol. 27, Iss. 4, pp. 363-377
Closed Access | Times Cited: 8
Bevacizumab-Induced Mitochondrial Dysfunction, Endoplasmic Reticulum Stress, and ERK Inactivation Contribute to Cardiotoxicity
Yue Li, Wei Tian, Dongsheng Yue, et al.
Oxidative Medicine and Cellular Longevity (2021) Vol. 2021, Iss. 1
Open Access | Times Cited: 20
Genetic Susceptibility and Mechanisms Underlying the Pathogenesis of Anthracycline-Associated Cardiotoxicity
Yonghe Ding, Ke Du, Yujuan Niu, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-10
Open Access | Times Cited: 13
Positron Emission Tomography in Heart Failure: From Pathophysiology to Clinical Application
Gregorio Tersalvi, Vittorio Beltrani, Martin Grübler, et al.
Journal of Cardiovascular Development and Disease (2023) Vol. 10, Iss. 5, pp. 220-220
Open Access | Times Cited: 7
Approaches for reducing chemo/radiation-induced cardiotoxicity by nanoparticles
Ketao Li, Wan Chen, Liping Ma, et al.
Environmental Research (2023) Vol. 244, pp. 117264-117264
Closed Access | Times Cited: 7
Translational Proteomics Analysis of Anthracycline-Induced Cardiotoxicity From Cardiac Microtissues to Human Heart Biopsies
Nhan Nguyen, Terezinha Souza, Marcha Verheijen, et al.
Frontiers in Genetics (2021) Vol. 12
Open Access | Times Cited: 17
Cardio-oncology in Austria: cardiotoxicity and surveillance of anti-cancer therapies
Jutta Bergler‐Klein, Peter P. Rainer, Markus Wallner, et al.
Wiener klinische Wochenschrift (2022) Vol. 134, Iss. 17-18, pp. 654-674
Open Access | Times Cited: 12
Mitotherapy in doxorubicin induced cardiotoxicity: A promising strategy to reduce the complications of treatment
Farshid Maleki, Mona Salimi, Reza Shirkoohi, et al.
Life Sciences (2022) Vol. 304, pp. 120701-120701
Closed Access | Times Cited: 9
Cardiac MRI assessment of anthracycline-induced cardiotoxicity
Leila Mabudian, Jennifer H. Jordan, Wendy Bottinor, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 9
Seaweed Sargassum aquifolium extract ameliorates cardiotoxicity induced by doxorubicin in rats
Rania Samir, Ekrami A. Hassan, Abdullah A. Saber, et al.
Environmental Science and Pollution Research (2023) Vol. 30, Iss. 20, pp. 58226-58242
Open Access | Times Cited: 5
Moringa oleifera Leaves Extract Ameliorates Doxorubicin-Induced Cardiotoxicity via Its Mitochondrial Biogenesis Modulatory Activity in Rats
Cyntia Gracesella Hutami Patintingan, Melva Louisa, Vetnizah Juniantito, et al.
Journal of Experimental Pharmacology (2023) Vol. Volume 15, pp. 307-319
Open Access | Times Cited: 5
Lower cardiotoxicity of CPX-351 relative to daunorubicin plus cytarabine free-drug combination in hiPSC-derived cardiomyocytes in vitro
Marie Fortin, Andrew S. LaCroix, Tom N. Grammatopoulos, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 5
Molecular-Level Understanding of the Anticancer Action Mechanism of Anthracyclines
Manish Shandilya, Shrutika Sharma, Prabhu Prasad Das, et al.
IntechOpen eBooks (2020)
Open Access | Times Cited: 13
The Human Fetal and Adult Stem Cell Secretome Can Exert Cardioprotective Paracrine Effects against Cardiotoxicity and Oxidative Stress from Cancer Treatment
Federico Villa, Silvia Bruno, Ambra Costa, et al.
Cancers (2021) Vol. 13, Iss. 15, pp. 3729-3729
Open Access | Times Cited: 12
Benazepril hydrochloride protects against doxorubicin cardiotoxicity by regulating the PI3K/Akt pathway
Lan Zhan, Xiangxiu Wang, Yanjing Zhang, et al.
Experimental and Therapeutic Medicine (2021) Vol. 22, Iss. 4
Open Access | Times Cited: 11
Guarding the heart: How SGLT-2 inhibitors protect against chemotherapy-induced cardiotoxicity
Reza Golchin Vafa, Amirreza Sabahizadeh, Ramina Mofarrah
Current Problems in Cardiology (2023) Vol. 49, Iss. 3, pp. 102350-102350
Closed Access | Times Cited: 4
Statins for the Primary Prevention of Anthracycline Cardiotoxicity: A Comprehensive Review
Varun Bhasin, Azin Vakilpour, Marielle Scherrer‐Crosbie
Current Oncology Reports (2024) Vol. 26, Iss. 10, pp. 1197-1204
Open Access | Times Cited: 1
Gallic acid inhibits celecoxib-induced mitochondrial permeability transition and reduces its toxicity in isolated cardiomyocytes and mitochondria
Ahmad Salimi, Saman Atashbar, Mohammad Shabani
Human & Experimental Toxicology (2021) Vol. 40, Iss. 12_suppl, pp. S530-S539
Open Access | Times Cited: 9
Idarubicin-induced oxidative stress and apoptosis in cardiomyocytes: An in vitro molecular approach
Y Zhang, Qi Li, Dongsheng Xu, et al.
Human & Experimental Toxicology (2021) Vol. 40, Iss. 12_suppl, pp. S553-S562
Open Access | Times Cited: 8
Biomarker Determinants of Early Anthracycline-Induced Left Ventricular Dysfunction in Breast Cancer: A Systematic Review and Meta-Analysis
Stavroula Kastora, Tiberiu A. Pana, Yusuf Sarwar, et al.
Molecular Diagnosis & Therapy (2022) Vol. 26, Iss. 4, pp. 369-382
Closed Access | Times Cited: 6
Pharmaceutical Prevention and Management of Cardiotoxicity in Hematological Malignancies
Anastasia Perpinia, Nikolaos P.E. Kadoglou, Maria Vardaka, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 8, pp. 1007-1007
Open Access | Times Cited: 5
Cardiogenic shock among cancer patients
Anaïs Curtiaud, Clément Delmas, Justine Gantzer, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 5
Can antioxidant vitamins avoid the cardiotoxicity of doxorubicin in treating breast cancer?
Iago Dillion Lima Cavalcanti, José Cleberson Santos Soares, Sandrelli Meridiana de Fátima Ramos dos Santos Medeiros, et al.
PharmaNutrition (2021) Vol. 16, pp. 100259-100259
Closed Access | Times Cited: 7
Combat Doxorubicin Cardiotoxicity With the Power of Mitochondria Transfer
Dennis D. Wang, Richard K. Cheng, Rong Tian
JACC CardioOncology (2021) Vol. 3, Iss. 3, pp. 441-443
Open Access | Times Cited: 7
The emerging therapeutic role of mesenchymal stem cells in anthracycline-induced cardiotoxicity
Huanrong Lan, Qi Xue, Yuyao Liu, et al.
Cell and Tissue Research (2021) Vol. 384, Iss. 1, pp. 1-12
Closed Access | Times Cited: 6

Scroll to top